PMID: 6540685Aug 1, 1984Paper

Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study

European Journal of Cancer & Clinical Oncology
J A ElliottK C Calman

Abstract

One hundred and five patients with inoperable non-small cell lung cancer were included in a randomized trial comparing the activity of vindesine as a single agent with the combination of vindesine and cisplatin. All patients were previously untreated and the majority (70%) had squamous carcinoma. The overall partial response rates in 88 evaluable patients were 7% for vindesine alone and 33% for the combined regime. There were no complete responders in either arm. The median survival of patients treated with vindesine and cisplatin was 11 months, compared with 4 months in those treated with vindesine alone (P = 0.008). Patients showing a partial or complete response to vindesine and cisplatin survived a median duration of 13 months, compared with 7 months for non-responders (P = 0.03). This survival benefit associated with the combination was particularly apparent for patients with ECOG performance status 0 or 1 (median survival greater than 18 months and 13 months respectively), locoregional disease (median survival 14 months) and squamous cell histology (median survival 13 months). Myelo-suppression was greater with the combination but was not a major treatment problem. Neurotoxicity, which was frequently dose-limiting, was of...Continue Reading

Citations

Jan 1, 1992·Lung·A B Sandler, A C Buzaid
May 1, 1993·Investigational New Drugs·J B Sørensen, H H Hansen
Oct 1, 1991·Pharmacology & Therapeutics·E K Rowinsky, R C Donehower
Jun 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·P JacouletA Depierre
Aug 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·P MarinoG Buccheri
Mar 1, 1987·Cancer Treatment Reviews·J B SørensenH H Hansen
Jan 1, 1992·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·U Abel
Nov 12, 1992·The New England Journal of Medicine·D C Ihde
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P A IoannidisN Pavlidis
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E LaackD K Hossfeld
Jun 7, 2000·Journal of Experimental & Clinical Cancer Research : CR·C MassacesiA Piga
Aug 1, 1987·Seminars in Oncology Nursing·K V Harwood
Jul 1, 1989·European Journal of Cancer & Clinical Oncology·J Klastersky
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J O'DwyerR L Comis
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T ShinkaiN Saijo
Mar 16, 2001·Expert Opinion on Pharmacotherapy·I Sekine, N Saijo
May 1, 1996·Chest·N ThatcherH Anderson
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giannicola D'AddarioFrances A Shepherd
Jun 1, 1986·Journal of Clinical and Hospital Pharmacy·G F Benfield, M H Cullen
May 1, 1991·Current Problems in Cancer·D C Ihde, J D Minna
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T A Splinter
Apr 1, 1986·European Journal of Cancer & Clinical Oncology·J A Elliott
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Catherine DelbaldoJean Pierre Pignon
May 1, 1989·Postgraduate Medical Journal·C G Price, M L Slevin
Oct 10, 2002·British Journal of Cancer·J Cosaert, E Quoix
May 7, 1998·Endocrine Reviews·S C YeungR F Gagel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.